237 related articles for article (PubMed ID: 29292157)
1. The monoamine-oxidase B inhibitor deprenyl increases selection of high-effort activity in rats tested on a progressive ratio/chow feeding choice procedure: Implications for treating motivational dysfunctions.
Yohn SE; Reynolds S; Tripodi G; Correa M; Salamone JD
Behav Brain Res; 2018 Apr; 342():27-34. PubMed ID: 29292157
[TBL] [Abstract][Full Text] [Related]
2. Partial reversal of the effort-related motivational effects of tetrabenazine with the MAO-B inhibitor deprenyl (selegiline): Implications for treating motivational dysfunctions.
Contreras-Mora H; Rowland MA; Yohn SE; Correa M; Salamone JD
Pharmacol Biochem Behav; 2018 Mar; 166():13-20. PubMed ID: 29309800
[TBL] [Abstract][Full Text] [Related]
3. The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio/chow feeding choice task: reversal with antidepressant drugs.
Randall PA; Lee CA; Nunes EJ; Yohn SE; Nowak V; Khan B; Shah P; Pandit S; Vemuri VK; Makriyannis A; Baqi Y; Müller CE; Correa M; Salamone JD
PLoS One; 2014; 9(6):e99320. PubMed ID: 24937131
[TBL] [Abstract][Full Text] [Related]
4. Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression.
Nunes EJ; Randall PA; Hart EE; Freeland C; Yohn SE; Baqi Y; Müller CE; López-Cruz L; Correa M; Salamone JD
J Neurosci; 2013 Dec; 33(49):19120-30. PubMed ID: 24305809
[TBL] [Abstract][Full Text] [Related]
5. Bupropion increases selection of high effort activity in rats tested on a progressive ratio/chow feeding choice procedure: implications for treatment of effort-related motivational symptoms.
Randall PA; Lee CA; Podurgiel SJ; Hart E; Yohn SE; Jones M; Rowland M; López-Cruz L; Correa M; Salamone JD
Int J Neuropsychopharmacol; 2014 Oct; 18(2):. PubMed ID: 25575584
[TBL] [Abstract][Full Text] [Related]
6. Blockade of uptake for dopamine, but not norepinephrine or 5-HT, increases selection of high effort instrumental activity: Implications for treatment of effort-related motivational symptoms in psychopathology.
Yohn SE; Errante EE; Rosenbloom-Snow A; Somerville M; Rowland M; Tokarski K; Zafar N; Correa M; Salamone JD
Neuropharmacology; 2016 Oct; 109():270-280. PubMed ID: 27329556
[TBL] [Abstract][Full Text] [Related]
7. The novel atypical dopamine transport inhibitor CT-005404 has pro-motivational effects in neurochemical and inflammatory models of effort-based dysfunctions related to psychopathology.
Rotolo RA; Presby RE; Tracy O; Asar S; Yang JH; Correa M; Murray F; Salamone JD
Neuropharmacology; 2021 Feb; 183():108325. PubMed ID: 32956676
[TBL] [Abstract][Full Text] [Related]
8. Behavioral and dopamine transporter binding properties of the modafinil analog (S, S)-CE-158: reversal of the motivational effects of tetrabenazine and enhancement of progressive ratio responding.
Rotolo RA; Kalaba P; Dragacevic V; Presby RE; Neri J; Robertson E; Yang JH; Correa M; Bakulev V; Volkova NN; Pifl C; Lubec G; Salamone JD
Psychopharmacology (Berl); 2020 Nov; 237(11):3459-3470. PubMed ID: 32770257
[TBL] [Abstract][Full Text] [Related]
9. Adenosine A(2A) receptor antagonism reverses the effects of dopamine receptor antagonism on instrumental output and effort-related choice in the rat: implications for studies of psychomotor slowing.
Farrar AM; Pereira M; Velasco F; Hockemeyer J; Müller CE; Salamone JD
Psychopharmacology (Berl); 2007 Apr; 191(3):579-86. PubMed ID: 17072593
[TBL] [Abstract][Full Text] [Related]
10. Effort-related motivational effects of the pro-inflammatory cytokine interleukin-6: pharmacological and neurochemical characterization.
Yohn SE; Arif Y; Haley A; Tripodi G; Baqi Y; Müller CE; Miguel NS; Correa M; Salamone JD
Psychopharmacology (Berl); 2016 Oct; 233(19-20):3575-86. PubMed ID: 27497935
[TBL] [Abstract][Full Text] [Related]
11. Nucleus accumbens and effort-related functions: behavioral and neural markers of the interactions between adenosine A2A and dopamine D2 receptors.
Farrar AM; Segovia KN; Randall PA; Nunes EJ; Collins LE; Stopper CM; Port RG; Hockemeyer J; Müller CE; Correa M; Salamone JD
Neuroscience; 2010 Apr; 166(4):1056-67. PubMed ID: 20096336
[TBL] [Abstract][Full Text] [Related]
12. Effects of lisdexamfetamine and s-citalopram, alone and in combination, on effort-related choice behavior in the rat.
Yohn SE; Lopez-Cruz L; Hutson PH; Correa M; Salamone JD
Psychopharmacology (Berl); 2016 Mar; 233(6):949-60. PubMed ID: 26694811
[TBL] [Abstract][Full Text] [Related]
13. Forebrain circuitry involved in effort-related choice: Injections of the GABAA agonist muscimol into ventral pallidum alter response allocation in food-seeking behavior.
Farrar AM; Font L; Pereira M; Mingote S; Bunce JG; Chrobak JJ; Salamone JD
Neuroscience; 2008 Mar; 152(2):321-30. PubMed ID: 18272291
[TBL] [Abstract][Full Text] [Related]
14. Rats bred for helplessness exhibit positive reinforcement learning deficits which are not alleviated by an antidepressant dose of the MAO-B inhibitor deprenyl.
Schulz D; Henn FA; Petri D; Huston JP
Neuroscience; 2016 Aug; 329():83-92. PubMed ID: 27163379
[TBL] [Abstract][Full Text] [Related]
15. Nucleus accumbens neurotransmission and effort-related choice behavior in food motivation: effects of drugs acting on dopamine, adenosine, and muscarinic acetylcholine receptors.
Nunes EJ; Randall PA; Podurgiel S; Correa M; Salamone JD
Neurosci Biobehav Rev; 2013 Nov; 37(9 Pt A):2015-25. PubMed ID: 23583616
[TBL] [Abstract][Full Text] [Related]
16. Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5/ chow feeding choice task.
Nunes EJ; Randall PA; Estrada A; Epling B; Hart EE; Lee CA; Baqi Y; Müller CE; Correa M; Salamone JD
Psychopharmacology (Berl); 2014 Feb; 231(4):727-36. PubMed ID: 24136220
[TBL] [Abstract][Full Text] [Related]
17. Sex differences in lever pressing and running wheel tasks of effort-based choice behavior in rats: Suppression of high effort activity by the serotonin transport inhibitor fluoxetine.
Presby RE; Rotolo RA; Hurley EM; Ferrigno SM; Murphy CE; McMullen HP; Desai PA; Zorda EM; Kuperwasser FB; Carratala-Ros C; Correa M; Salamone JD
Pharmacol Biochem Behav; 2021 Mar; 202():173115. PubMed ID: 33493546
[TBL] [Abstract][Full Text] [Related]
18. The role of dopamine D1 receptor transmission in effort-related choice behavior: Effects of D1 agonists.
Yohn SE; Santerre JL; Nunes EJ; Kozak R; Podurgiel SJ; Correa M; Salamone JD
Pharmacol Biochem Behav; 2015 Aug; 135():217-26. PubMed ID: 26022661
[TBL] [Abstract][Full Text] [Related]
19. Not All Antidepressants Are Created Equal: Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior.
Yohn SE; Collins SL; Contreras-Mora HM; Errante EL; Rowland MA; Correa M; Salamone JD
Neuropsychopharmacology; 2016 Feb; 41(3):686-94. PubMed ID: 26105139
[TBL] [Abstract][Full Text] [Related]
20. Assessment of a glycine uptake inhibitor in animal models of effort-related choice behavior: implications for motivational dysfunctions.
Yohn SE; Alberati D; Correa M; Salamone JD
Psychopharmacology (Berl); 2017 May; 234(9-10):1525-1534. PubMed ID: 28083675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
